TITLE

Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors

AUTHOR(S)
Liu, Z.; Klominek, J.
PUB. DATE
March 2003
SOURCE
Thorax;Mar2003, Vol. 58 Issue 3, p198
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Investigates the effects of different growth factors on production of matrix metalloproteases in malignant mesothelioma cells. Methods; Results; Discussion.
ACCESSION #
9360664

 

Related Articles

  • In silico Identification of New Antiproliferative Compounds, Inhibitors of Matrix Metalloproteinases. Sevastre, Bogdan; Marcus, Ioan; Tamaian, Radu // Bulletin of the University of Agricultural Sciences & Veterinary;2011, Vol. 68 Issue 1, p334 

    Tenascin C (TNC) is a glycoprotein of the extracellular matrix and its overexpression induced by matrix metalloproteinases (MMPs) is associated with the amplification of the proliferative response to growth factors, promotion of cancer cell invasion and tumoral growth. This paper looks forward...

  • The epoxyeicosatrienoic acid-stimulated phosphorylation of EGF-R involves the activation of metalloproteinases and the release of HB-EGF in cancer cells. Li-ming CHENG; Jian-gang JIANG; Zi-yong SUN; Chen CHEN; DACKOR, Ryan T.; ZELDIN, Darryl C.; Dao-wen WANG // Acta Pharmacologica Sinica;Feb2010, Vol. 31 Issue 2, p211 

    AbstractAim:To test the hypothesis that the epoxyeicosatrienoic acid (EET)-induced transactivation of EGF-R depends on the activation of metalloproteinases and the subsequent release of HB-EGF in cancer cells.Methods:Exogenous 14,15-EET were added to four human-derived cancer cell lines...

  • Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway. Tan, X.; Egami, H.; Abe, M.; Nozawa, F.; Hirota, M.; Ogawa, M. // Journal of Clinical Pathology;Dec2005, Vol. 58 Issue 12, p1242 

    Aims: To clarify the involvement of matrix metalloproteinase-7 (MMP-7) in cell dissociation and the subsequent invasion of pancreatic cancer cells. Methods: Western blotting, in vitro invasion assay, immunocytochemistry, and immunohistochemistry were performed in pancreatic cancer cell lines or...

  • Correlation of Tissue Inhibitor of Metalloproteinase-2 with Proliferative Activity and Patients’ Survival in Breast Cancer. Nakopoulou, Lydia; Katsarou, Sophia; Giannopoulou, Joanna; Alexandrou, Paraskevi; Tsirmpa, Joanna; Panayotopoulou, Effie; Mavrommatis, Johnny; Keramopoulos, Antonios // Modern Pathology;Jan2002, Vol. 15 Issue 1, p26 

    Tissue inhibitors of metalloproteinases (TIMPs) are endogenous regulators of matrix metalloproteinases (MMPs). They are believed to possess several distinct cellular functions, particularly the contradictory activities of inhibiting MMPs and promoting tumor cell growth. Immunohistochemistry was...

  • Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation. Yu, Xiaoping; Zhu, Jundong; Mi, Mantian; Chen, Wei; Pan, Qu; Wei, Min // Medical Oncology;Mar2012, Vol. 29 Issue 1, p349 

    Genistein (Gen), a soy isoflavone, is considered to exert potent antitumor effect partially through its anti-angiogenesis property. However, the precise molecular mechanism is still unknown. Our previous investigations have demonstrated that genistein down-regulates expression of pro-angiogenic...

  • Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells. Ji-Young Jang; Yoon-Kyung Jeon; Chul-Woo Kim // BMC Cancer;2010, Vol. 10, p391 

    Background: In breast cancer, the HER2/neu oncoprotein, which belongs to the epidermal growth factor receptor family, may trigger activation of the phosphoinositide-3 kinase (PI3K)/Akt pathway, which controls cell proliferation, survival, migration, and invasion. In this study, we examined the...

  • Targeted Inhibition of Multiple Receptor Tyrosine Kinases in Mesothelioma. Wen-Bin Ou; Hubert, Christopher; Corson, Joseph M.; Bueno, Raphael; Flynn, Daniel L.; Sugarbaker, David J.; Fletcher, Jonathan A. // Neoplasia;Jan2011, Vol. 13 Issue 1, p12 

    The receptor tyrosine kinases (RTKs) epidermal growth factor receptor (EGFR) and MET are activated in subsets of mesothelioma, suggesting that these kinases might represent novel therapeutic targets in this notoriously chemotherapy-resistant cancer. However, clinical trials have shown little...

  • The Growth Factor Midkine Antagonizes VEGF Signaling In Vitro and In Vivo. van der Horst, Edward Htun; Frank, Brendon T.; Chinn, Lawrence; Coxon, Angela; Shyun Li; Polesso, Fanny; Slavin, Anthony; Ruefli-Brasse, Astrid; Wesche, Holger // Neoplasia;Apr2008, Vol. 10 Issue 4, p340 

    Midkine (MDK) is a heparin-binding growth factor involved in growth, survival, migration, and differentiation of various target cells and dysregulation of MDK signaling is implicated in a variety of inflammatory diseases and cancers. Although MDK has been reported to act on endothelial cells and...

  • Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer. Hiroshi Kawaguchi; Yoshito Terai; Akiko Tanabe; Hiroshi Sasaki; Masaaki Takai; Satoe Fujiwara; Keisuke Ashihara; Yoshimichi Tanaka; Tomohito Tanaka; Satoshi Tsunetoh; Masanori Kanemura; Masahide Ohmichi // Journal of Ovarian Research;2014, Vol. 7 Issue 1, p1 

    Background Gemcitabine (2', 2'-difluorodeoxycytidine) is one of many nonplatinum drugs that exhibit activity in recurrent, platinum-resistant ovarian cancer. However, the molecular mechanisms by which Gemcitabine treatment inhibits the proliferation of platinum-resistant ovarian cancer cells...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics